EDGAR Filing Documents for 0000950123-09-005040

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0000950123-09-005040

Filing Date

2009-03-20

Accepted

2009-03-20 13:21:26

Documents

Period of Report

2008-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT TO FORM 20-F	y75427e20vfza.htm	20-F/A	32721
2	EX-4.10: PATENT LICENSE AGREEMENT	y75427exv4w10.htm	EX-4.10	83703
3	EX-4.11: AMENDMENT TO PATENT LICENSE AGREEMENT	y75427exv4w11.htm	EX-4.11	34360
4	EX-12.1: CERTIFICATION	y75427exv12w1.htm	EX-12.1	5520
5	EX-12.2: CERTIFICATION	y75427exv12w2.htm	EX-12.2	5738
6	EX-13.1: CERTIFICATION	y75427exv13w1.htm	EX-13.1	4679
	Complete submission text file	0000950123-09-005040.txt		168088

Mailing Address 107 NORTH RYDE SYDNEY C3 1670

Business Address 140 WICKS RD NORTH RYDE NEW SOUTH WALES 2113 C3 2113 01161298780088

NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 20-F/A | Act: 34 | File No.: 000-29962 | Film No.: 09695475
SIC: 2834 Pharmaceutical Preparations